![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Warns Compounding Pharmacy Trio With cGMP Violations
FDA Warns Compounding Pharmacy Trio With cGMP Violations
The FDA cited a trio of compounders for a wide swath of quality violations, igniting renewed criticism that the agency is “unjustified” in using a new law to enforce old violations.
Drug Industry Daily
Upcoming Events
-
21Oct